The Health-Systems Pharmacy section will be under the editorial direction of James C. McAllister, III, MS, FASHP, a nationally recognized hospital pharmacy leader. Mr. McAllister had over 20 years of practice at Duke University Medical Center in various roles including Director of Pharmacy and Associate Chief Operating Officer. He currently serves as Director of Pharmacy at the University of North Carolina Hospitals & Clinics and Clinical Professor and Associate Dean for Clinical Affairs at the UNC School of Pharmacy. He has served as a member of the Board and President of ASHP as well as the state organization.
Content will focus on the pharmacist's role in traditional operations and clinical care, but it will also include pharmacy practice in various organized health care settings intended to reflect the broad scope of health systems practice for pharmacists, including investigational drug services, practice in the perioperative environment, leadership and practice in improving medication safety, and the evolution of pharmacy information technology. We will attempt to include timely topics such as expansion of consultation services, expanded roles in hospital ambulatory care environments, collaborative practice models, pharmacist-led admission history and discharge counseling services, formulary management strategies, pharmacoeconomics, and initiatives to improve continuum of care services among practitioners in different settings.
Written in the same style you have come to expect in Pharmacy Times: authoritative, relevant, articles with practical applications that can be read quickly.
Continuity of care is recognized as an important element of effective health care, and who is better positioned than the pharmacist? From the hospital pharmacists to community, patient records and care plans require continuity. PT covers all aspects of pharmacy.
We look forward to receiving hospital pharmacists' opinions on content and direction. Please tell us how best to meet your needs.
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs